Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




Zacks Analyst Blog Highlights: Sepracor, Inc., Raytheon Co., AstraZeneca PLC, GATX Corporation and Tetra Tech, Inc. – Press Releases

Zacks Market Commentaries (May 4th, 2009) Writes:
For Immediate Release

Chicago, IL - May 4, 2009 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Sepracor, Inc. (SEPR), Raytheon Co. (RTN), AstraZeneca PLC (AZN), GATX Corporation (GMT) and Tetra Tech, Inc. (TTEK).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579.

Here are highlights from Friday's Analyst Blog:

Sepracor Building a Base

Business fundamentals at Sepracor, Inc. (SEPR) have been poor over the past several quarters. Lunesta growth disappointed throughout 2008 and guidance for 2009 assumes sales will decline between 5% and 10%.

Likewise, Xopenex and Xopenex HFA also disappointed

...

Tetra Tech: Waiting for ARRA! – Analyst Blog

Zacks Market Commentaries (May 1st, 2009) Writes:
Tetra Tech, Inc. (TTEK) had predicted that Q2-09 EPS would be in the range of 24¢ to 26¢; the precise, actual number was 31.6¢, which included 5.5¢ from the impact of an IRS tax settlement, which, if excluded from the results, brings the remainder down to 26.1¢.Such accuracy is indeed commendable -- and especially noteworthy -- for a hi-tech company the ilk of TTEK. However, on a slightly less-accurate basis, 26¢ is but 13.0% higher than the 23¢ reported in Q2-08. In Q1-09, EPS were up 22.7%. Consequently, a bit of slowing can be detected in these numbers, part of which can be attributed to the recent Wardrop acquisition. However, if we drill down further into the results, we find that there are other similar indicators.Specifically, Q2-09 Revenues of $522.3 million were up by 13.2%, while Revenues in Q1-09 rose by 35.8%. If we ...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.